Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kyle Lefkoff Insider Profile
4 Followers
Kyle Lefkoff, Director at Array Biopharma, holds 65.00K shares in Array Biopharma (Ticker: ~ARRY), holds 2.11M shares in Miragen Therapeutics (Ticker: MGEN).
Profitable Transactions
9 out of 15 Profitable Transactions
Average Return
+4.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Kyle Lefkoff holds in companies
Most Profitable Insider Trade
Stock:
Array Biopharma
(~ARRY)
(~ARRY)
Rating:Informative Buy
Date:Aug 11, 2011 - Aug 11, 2012
Return:+99.50%
The most profitable trade made by Kyle Lefkoff
Kyle Lefkoff's Trading History
Array Biopharma
Jul 30, 2019
―
Uninformative Sell
2.05M
$3.11M
Miragen Therapeutics
Mar 13, 2017
Director
Informative Sell
83.17K
$35.69M
List of latest transactions for each holding click on a transaction to see Kyle Lefkoff's performance on stock
You May Also Like
Kyle Lefkoff insider profile FAQ
What is the percentage of profitable transactions made by Kyle Lefkoff?
The percentage of profitable transactions made by Kyle Lefkoff is 60%.
What is the average return per transaction made by Kyle Lefkoff?
The average return per transaction made by Kyle Lefkoff is 4.70%.
What stocks does Kyle Lefkoff hold?
Kyle Lefkoff holds: ~ARRY, MGEN stocks.
What was Kyle Lefkoff’s latest transaction?
Kyle Lefkoff latest transaction was an Uninformative Sell of $2.05M.
What was Kyle Lefkoff's most profitable transaction?
Kyle Lefkoff’s most profitable transaction was an Informative Buy of ~ARRY stock on August 11, 2011. The return on the trade was 99.50%.
What is Kyle Lefkoff's role in Array Biopharma?
Kyle Lefkoff's role in Array Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.